MNST
61
2
CMCSA
48
2
JCI
45
4
CMI
42
4
DNB
60
2
VZ
54
-3
DVA
71
5
TRV
59
7
C
51
3
WYNN
37
3
DGX
57
3
ISRG
57
3
MOS
45
3
ZBH
65
3
BEN
34
4
VRSK
66
-2
EIX
47
4
NFLX
65
3
SYF
58
3
SWKS
44
2
MNST
61
2
CMCSA
48
2
JCI
45
4
CMI
42
4
DNB
60
2
VZ
54
-3
DVA
71
5
TRV
59
7
C
51
3
WYNN
37
3
DGX
57
3
ISRG
57
3
MOS
45
3
ZBH
65
3
BEN
34
4
VRSK
66
-2
EIX
47
4
NFLX
65
3
SYF
58
3
SWKS
44
2
Financhill
Back

Integra Lifesciences Holdings 10K Form

Sell
20

IART
Integra Lifesciences Holdings

Last Price:
$22.34
Seasonality Move:
2.19%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

2024-05-06 10Q IART/Integra Lifesciences Holdings Quarterly
2023-10-25 10Q IART/Integra Lifesciences Holdings Quarterly
2023-07-27 10Q IART/Integra Lifesciences Holdings Quarterly
2023-04-26 10Q IART/Integra Lifesciences Holdings Quarterly
2022-10-26 10Q IART/Integra Lifesciences Holdings Quarterly
2022-07-27 10Q IART/Integra Lifesciences Holdings Quarterly

Receive IART News And Ratings

See the #1 stock for the next 7 days that we like better than IART

IART Financial Statistics

Sales & Book Value

Annual Sales: $1.6B
Cash Flow: $11.2M
Price / Cash Flow: 114.66
Annual Sales: $20.03
Price / Book: 1.12

Profitability

EPS (TTM): -0.09000
Net Income (TTM): $-6.9M
Gross Margin: $882.1M
Return on Equity: -0.45%
Return on Assets: -0.17%

Integra Lifesciences Holdings Earnings Forecast

Key Integra Lifesciences Holdings Financial Ratios

  • The Gross Profit Margin over the past 30 years for IART is 54.77%.
  • The Selling, General & Administrative Expenses for IART have been equal to 44.52% of Gross Profit Margin.
  • The Research & Development expenses have been 7.16% of Revenue.
  • The Net Earning history of IART is -0.43% of Total Revenues.
  • Per Share Earnings over the last 30 years have been positive in 15 years.

Integra Lifesciences Holdings Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Equipment & Supplies
Sector: Health Care
Current Symbol: IART
CUSIP: 457985
Website: integralife.com

Debt

Debt-to-Equity Ratio: 1.17
Current Ratio: 1.17
Quick Ratio: 0.59

Price-to-Earnings

Trailing P/E Ratio: 29.43
Forward P/E Ratio: 8.22

IART Technical Analysis vs Fundamental Analysis

Sell
20
Integra Lifesciences Holdings (IART) is a Sell

Is Integra Lifesciences Holdings a Buy or a Sell?